Skip to content
DataLookout
Menu

NCT07278648

High-risk Antithrombotic Drugs at Discharge and Consultation for Hemorrhagic or Thromboembolic Events in the Emergency Department

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Mar 1, 2026 to Mar 1, 2027
    • Start date: Feb 5, 2026 to Feb 5, 2027
    • Eligibility criteria expanded, about 3 words
  2. Notable Start date: Dec 5, 2025 to Feb 5, 2026v2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Hemorragic event
Timeframe: Day 90 from baseline

Arms and interventions

Anticoagulant therapy

Patients who has been discharged from hospital with anticoagulant therapy

Other: Antithrombotic therapy

Sites

1 site in 1 country

  • Hospital de VilafrancaVilafranca del Penedès, Barcelona, Spain